Novel, Non–anti-amyloid Shows Early Promise in Alzheimer's

Rather than targeting brain amyloid this new investigational drug focuses on an earlier underlying driver of Alzheimer's disease.

Related Keywords

United Kingdom , ,Fbio Ltd ,Oxford University In ,Drug Administration ,Medicines Healthcare Products Regulatory Agency ,Translational Research Clinical Interventions ,Neuro Bio Ltd ,Baroness Susan Greenfield ,Oxford University ,Medscape Medical ,Translational Research ,Healthcare Products Regulatory Agency ,Alzheimers Disease ,Lzheimer Disease ,Dementia ,Amyloid Plaque ,Neurotoxins ,Brain ,